- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02945371
Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life (REV)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oregon
-
Eugene, Oregon, United States, 97403
- University of Oregon, Social and Affective Neuroscience Laboratory
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 35-55
- Experience of early adversity (EA) before age 18 (EA is be defined as a score of 4 or higher on the Adverse Childhood Experiences (ACEs) questionnaire [Felitti, Anda, Nordenberg, Williamson, Spitz, Edwards, et al., 1998])
- IC difficulties such as disinhibited alcohol use, tobacco use, or food intake during adulthood. IC difficulties will be self-reported based on questions from the self-control questionnaire (Tangney, Baumeister, & Boone, 2004) modified to be specific to alcohol, tobacco, and energy-dense food intake (e.g., "I am self-indulgent with unhealthy food at times", "I refuse alcohol when offered") using a 4-point Likert-style scale.
Exclusion Criteria:
- Individuals over age 55 will be excluded because of established functional and structural neural changes that begin to escalate at that time (Good, Johnsrude, Ashburner, Henson, Friston, & Frackowiak, 2001; Grady, Springer, Hongwanishkul, McIntosh, & Winocur, 2006)
- Given the high rates of morbidity for such disorders among people with high EA, we will not exclude based on past diagnoses for any of those disorders or based on current drug and alcohol use. However, we will exclude individuals who do not pass a urine toxicology screen during either of the functional magnetic resonance imaging (fMRI) sessions to ensure that the neuroimaging data are as homogeneous and reliable as possible.
- Participants who cannot undergo an MRI scan will be excluded; contraindications include metal implants (e.g., braces, pins) or metal fragments, pacemakers or other electronic medical implants, claustrophobia, pregnancy, and weight greater than 550 lbs.
Beyond these criteria, participants will be recruited without exclusions based on gender, race, or ethnicity, so our sample will reflect the diversity in the local population (Lane County, Oregon) with regard to gender, race, and ethnicity.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: IC Training
The experimental arm (ARM1) is a "person-centered inhibitory control" training intervention, or PeCIC. Between the baseline and endpoint sessions, participants come to our lab 12 times to participate in the training sessions. Each participant is randomly assigned to either the PeCIC training or an active control training. The training sessions will take place approx. every other day for 24 days. Beginning 2-3 days after the baseline session, the experimental group (will come to our behavioral testing lab to receive the PeCIC training. At 11 sessions spaced one every other day, participants will complete one 8-min run of a modified stop-signal task. The cue on each trial (preceding the "go" signal arrow) will be an image of a personalized risk-cue (PRC) or a neural image. |
A brief, computer-based, multisession training aimed at increasing the connection between environmental risk cues (e.g., cigarettes) and engagement of the brain network for inhibitory control.
Other Names:
|
|
Active Comparator: Control Training
Participants in the active control group (ARM2) of the PeCIC intervention will come to the behavioral testing laboratory to complete an 8-min control task every other day for 12 sessions.
This control task is identical to the PeCIC except the auditory stop cues are omitted.
All other procedures, settings, and schedules are identical to those in the experimental group.
The only difference between the groups is that the active control does not practice IC.
|
A brief computer-based, multisession training aimed at training behavioral responses to personalized environmental risk cues (e.g., cigarettes) that does not engage the inhibitory control network of the brain.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inhibitory control performance, Task 1
Time Frame: 1 month
|
Performance on a standard inhibitory control task (Stop-Signal) with personal risk cues
|
1 month
|
|
Inhibitory control performance, Task 2
Time Frame: 1 month
|
Performance on a standard inhibitory control task (Go/No-Go) with personal risk cues
|
1 month
|
|
Inhibitory control neural activity
Time Frame: 1 month
|
Early ("proactive") engagement of the inferior frontal gyrus and dorsal anterior cingulate cortex during the inhibitory control tasks
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Far transfer to a task related to inhibitory control, Behavioral marker
Time Frame: 1 month
|
Performance on a standard risky-behavior task (Balloon Analogue Risk task)
|
1 month
|
|
Far transfer to a task related to inhibitory control, Neural marker
Time Frame: 1 month
|
Neural activity during a standard risky-behavior task (Balloon Analogue Risk task)
|
1 month
|
|
Health-risking behavior
Time Frame: 1 month, 3 months
|
Standard self-report questions regarding health-risking behavior related to inhibitory control (e.g., cigarette smoking, excessive alcohol intake, illicit drug use and prescription drug misuse, and excessive energy intake)
|
1 month, 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Elliot T Berkman, PhD, University of Oregon
Publications and helpful links
General Publications
- Fisher PA, Berkman ET. Designing Interventions Informed by Scientific Knowledge About Effects of Early Adversity: A Translational Neuroscience Agenda for Next Generation Addictions Research. Curr Addict Rep. 2015 Dec 1;2(4):347-353. doi: 10.1007/s40429-015-0071-x. Epub 2015 Sep 28.
- Berkman ET, Lukinova E, Menshikov I, Myagkov M. Sociality as a natural mechanism of public goods provision. PLoS One. 2015 Mar 19;10(3):e0119685. doi: 10.1371/journal.pone.0119685. eCollection 2015.
- Giuliani NR, Tomiyama AJ, Mann T, Berkman ET. Prediction of daily food intake as a function of measurement modality and restriction status. Psychosom Med. 2015 Jun;77(5):583-90. doi: 10.1097/PSY.0000000000000187.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EPCS20613
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance-Related Disorders
-
University of Wisconsin, MadisonNational Institute on Drug Abuse (NIDA); Rush University Medical CenterCompletedSubstance-Related Disorders | Substance Use | Substance AbuseUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence | Substance Related Problem
-
Norwegian University of Science and TechnologyCompletedSubstance-related DisordersNorway
-
University Hospital, Basel, SwitzerlandPsychiatric Hospital of the University of BaselCompleted
-
University of LuebeckFederal Ministry of Health, GermanyCompletedSubstance-related Disorders
-
University of Illinois at Urbana-ChampaignCompletedSubstance-related Disorders
-
University of NebraskaCompletedSubstance-related Disorders | Alcohol-related DisordersUnited States
-
The Cleveland ClinicWithdrawnSubstance Use | Substance Use Disorders | Substance Abuse | Substance DependenceUnited States
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)Completed
-
Boston Children's HospitalCompletedSubstance-related DisordersUnited States
Clinical Trials on Person-centered inhibitory control training
-
Hacettepe UniversityRecruitingSubstance Use Disorder (SUD)Turkey (Türkiye)
-
Aalborg University HospitalCompleted
-
Hacettepe UniversityUnknown
-
King's College LondonUniversity of ExeterCompleted
-
Boston Children's HospitalNeuroscouting, L.L.C.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Drexel UniversityDrexel Coulter Translational Research Partnership ProgramCompletedBinge Eating | Inhibition (Psychology)United States
-
Sykehuset Innlandet HFNorwegian Department of Health and Social AffairsWithdrawnDementia | Behavioural DisordersNorway
-
Raquel Vilar LópezGovernment of SpainRecruitingOverweight and Obesity | Inhibition, PsychologicalSpain
-
University of Nevada, RenoNot yet recruitingHealthy AgingUnited States
-
Brigham Young UniversityCompletedOverweight and ObesityUnited States